Transcranial magnetic stimulation (TMS) is emerging as a significant alternative for individuals with treatment-resistant depression, particularly when standard antidepressant medications fail to provide adequate relief. TMS is a noninvasive therapy that utilizes magnetic pulses to stimulate specific brain regions associated with mood regulation. Traditionally, TMS treatment requires patients to attend clinics five days a week for six to eight weeks, which can pose challenges for those managing work, family, or health issues.
Recent research at UCLA Health has explored an accelerated TMS approach, termed "5x5," which involves five treatment sessions daily over five consecutive days. This study, published in the Journal of Affective Disorders, included 175 participants suffering from treatment-resistant depression. Results indicated that both the traditional and accelerated treatment schedules led to significant reductions in depressive symptoms, with no statistically significant differences in outcomes between the two methods.
Importantly, some individuals receiving the accelerated treatment did not show immediate improvement. However, follow-up assessments two to four weeks later revealed that these patients experienced a notable reduction in depression scores, suggesting that the benefits of TMS may continue to develop over time.
While the 5x5 approach shows promise, researchers noted that the standard six-week protocol performed better on certain long-term metrics. The study was not randomized, indicating that further controlled trials are necessary to solidify these findings. Additionally, TMS research is expanding to address other mental health conditions, such as obsessive-compulsive disorder and chronic pain, potentially establishing TMS as a key component of future mental health treatments.